Control of T cell reactivation by regulatory Qa-1-restricted CD8 + T cells

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 6585-6591

  Varthaman, Aditi ^a,b,c   Khallou Laschet, Jamila ^a,b,c   Clement, Marc ^a,b,c   Fornasa, Giulia ^a,b,c   Kim, Hye Jung ^d   Gaston, Anh Thu ^a,b,c   Dussiot, Michael ^a,b,c   Caligiuri, Giuseppina ^a,b,c   Herbelin, André ^b   Kaveri, Srinivas ^c   Cantor, Harvey ^d,e   Nicoletti, Antonino ^a,b,c  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; HLA DQA1 ANTIGEN; IMMUNOGLOBULIN G1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STAT6 PROTEIN; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGENIC AGENT; Q SURFACE ANTIGENS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EXPERIMENT; HEPATITIS; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VACCINATION; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; MOUSE MUTANT; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CONCANAVALIN A; FLOW CYTOMETRY; HEPATITIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOGENS; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; VACCINATION;

EID: 77953635469     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903109     Document Type: Article

References (30)

1. Walker, L. S., and A. K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2: 11-19.
2. Aldrich, C. J., A. DeCloux, A. S. Woods, R. J. Cotter, M. J. Soloski, and J. Forman. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79: 649-658.
3. +) T cell responses. Nat. Immunol. 3: 189-195.
4. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848.
5. Tompkins, S. M., J. R. Kraft, C. T. Dao, M. J. Soloski, and P. E. Jensen. 1998. Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b). J. Exp. Med. 188: 961-971. (Pubitemid 28433422)
6. Davies, A., S. Kalb, B. Liang, C. J. Aldrich, F. A. Lemonnier, H. Jiang, R. Cotter, and M. J. Soloski. 2003. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm. J. Immunol. 170: 5027-5033.
7. Lo, W. F., A. S. Woods, A. DeCloux, R. J. Cotter, E. S. Metcalf, and M. J. Soloski. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat. Med. 6: 215-218.
8. +) T cells. Proc. Natl. Acad. Sci. USA 95: 4533-4537.
9. + CTLs by TCR Vbeta-derived peptides bound to HLA-E. J. Immunol. 167: 3800-3808.
10. Ben-Nun, A., H. Wekerle, and I. R. Cohen. 1981. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292: 60-61.
11. Panoutsakopoulou, V., K. M. Huster, N. McCarty, E. Feinberg, R. Wang, K. W. Wucherpfennig, and H. Cantor. 2004. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J. Clin. Invest. 113: 1218-1224.
12. Tang, X., I. Maricic, N. Purohit, B. Bakamjian, L. M. Reed-Loisel, T. Beeston, P. Jensen, and V. Kumar. 2006. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+ T cells. J. Immunol. 177: 7645-7655.
13. Kumar, V., R. Tabibiazar, H. M. Geysen, and E. Sercarz. 1995. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154: 1941-1950.
14. Wilson, S. B., and T. L. Delovitch. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Natl. Rev. Immunol. 3: 211-222.
15. Griseri, T., L. Beaudoin, J. Novak, L. T. Mars, F. Lepault, R. Liblau, and A. Lehuen. 2005. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells. J. Immunol. 175: 2091-2101. (Pubitemid 41113814)
16. Hu, D., K. Ikizawa, L. Lu, M. E. Sanchirico, M. L. Shinohara, and H. Cantor. 2004. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5: 516-523.
17. Brossay, L., S. Tangri, M. Bix, S. Cardell, R. Locksley, and M. Kronenberg. 1998. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J. Immunol. 160: 3681-3688. (Pubitemid 28176068)
18. Harris, J. F., A. F. Chambers, and A. S. Tam. 1991. Modulation of clonal progression in B16F1 melanoma cells. Clin. Exp. Metastasis 9: 151-162.
19. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97: 5498-5503.
20. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203.
21. Song, E., S. K. Lee, J. Wang, N. Ince, N. Ouyang, J. Min, J. Chen, P. Shankar, and J. Lieberman. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9: 347-351.
22. Lider, O., M. Shinitzky, and I. R. Cohen. 1986. Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure. Ann. N. Y. Acad. Sci. 475: 267-273.
23. Lohse, A. W., F. Mor, N. Karin, and I. R. Cohen. 1989. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244: 820-822.
24. Fazilleau, N., C. Delarasse, C. H. Sweenie, S. M. Anderton, S. Fillatreau, F. A. Lemonnier, D. Pham-Dinh, and J. M. Kanellopoulos. 2006. Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice. Eur. J. Immunol. 36: 533-543.
25. + T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity 2: 185-194.
26. Smith, T. R., X. Tang, I. Maricic, Z. Garcia, S. Fanchiang, and V. Kumar. 2009. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties. J. Immunol. 182: 6959-6968.
27. + Treg-mediated suppression. Trends Immunol. 29: 337-342.
28. Mimran, A., F. Mor, P. Carmi, F. J. Quintana, V. Rotter, and I. R. Cohen. 2004. DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response. J. Clin. Invest. 113: 924-932.
29. Quintana, F. J., A. Mimran, P. Carmi, F. Mor, and I. R. Cohen. 2008. HSP60 as a target of anti-ergotypic regulatory T cells. PLoS ONE 3: e4026.
30. Mimran, A., F. Mor, F. J. Quintana, and I. R. Cohen. 2005. Anti-ergotypic T cells in naïve rats. J. Autoimmun. 24: 191-201.